FDA Investigation Strategy

Dr. Nick Oberheiden is a Go-To Thought Leader for 2021 for his coverage of FDA investigations.  NLR readers turn to Dr. Oberheiden’s experience conducting internal investigations and leading defense teams in whistleblower cases. Of particular note are Dr. Oberheiden’s articles on what to expect when facing an investigation by a government agency like the FDA, outlining practical information and strategies readers can use.